Real-world data support Takhzyro’s efficacy in Japanese HAE patients
Preventive treatment with Takhzyro (lanadelumab) reduced swelling attack frequency and improved quality of life in Japanese patients with hereditary angioedema (HAE), a small real-world study shows. The study, “Effect of lanadelumab on attack frequency and QoL in Japanese patients with hereditary angioedema: Report of five…